Revised upper limb module for spinal muscular atrophy: 12 month changes

iSMAC Consortium Group

Research output: Contribution to journalArticlepeer-review


INTRODUCTION: The aim of the study was to assess 12 month changes in upper limb function in patients affected by spinal muscular atrophy type 2 and 3.

METHODS: Longitudinal 12 month data was collected in 114 patients, 60 type 2 and 54 type 3, using the Revised Upper Limb Module.

RESULTS: The 12 month changes ranged between -7 and 9 (mean: -0.41; SD: 2.93). The mean changes were not significantly different between the three spinal muscular atrophy groups (-0.45 in type 2, -0.23 in non-ambulant type 3 and -0.34 in ambulant type 3, p = 0.96) and the relationship between 12 month change and age classes was not significantly different among the three types of SMA patients.

DISCUSSION: Our results confirm that the Module explores a wide range of functional abilities and can be used in ambulant and non-ambulant patients of different ages in conjunction with other functional scales. Muscle Nerve 59:426-430, 2019.

Original languageEnglish
Pages (from-to)426-430
Number of pages5
JournalMuscle and Nerve
Issue number4
Publication statusPublished - Apr 2019


  • Adolescent
  • Adult
  • Algorithms
  • Child
  • Child, Preschool
  • Disease Progression
  • Female
  • Health Status
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Muscular Atrophy, Spinal/pathology
  • Reference Standards
  • Spinal Muscular Atrophies of Childhood/pathology
  • Upper Extremity/pathology
  • Walking
  • Young Adult


Dive into the research topics of 'Revised upper limb module for spinal muscular atrophy: 12 month changes'. Together they form a unique fingerprint.

Cite this